Natural IgM switches the function of lipopolysaccharide-activated murine bone marrow-derived dendritic cells to a regulatory dendritic cell that suppresses innate inflammation

Journal of Immunology

Volumn 195, Issue 11, 2015, Pages 5215-5226

  Lobo, Peter I ^a   Schlegel, Kailo H ^a   Bajwa, Amandeep ^a   Huang, Liping ^a   Kurmaeva, Elvira ^a   Wang, Binru ^a   Ye, Hong ^a   Tedder, Thomas F ^b   Kinsey, Gilbert R ^a   Okusa, Mark D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN M; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RELA; IL10 PROTEIN, MOUSE; PDCD1 PROTEIN, MOUSE; RELA PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BINDING SITE; BONE MARROW DERIVED DENDRITIC CELL; CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; IMMUNOREGULATION; INFLAMMATION; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; DENDRITIC CELL; IMMUNOLOGY; KIDNEY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VASCULARIZATION;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; BONE MARROW CELLS; CELLS, CULTURED; DENDRITIC CELLS; IMMUNOGLOBULIN M; INFLAMMATION; INTERLEUKIN-10; KIDNEY; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; PROGRAMMED CELL DEATH 1 RECEPTOR; REPERFUSION INJURY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTOR RELA;

EID: 84948800025     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500052     Document Type: Article

References (30)

1. Lobo, P. I., K. L. Brayman, and M. D. Okusa. 2014. Natural IgM anti-leucocyte autoantibodies (IgM-ALA) regulate inflammation induced by innate and adaptive immune mechanisms. J. Clin. Immunol. 34(Suppl. 1): S22-S29.
2. Hayakawa, K. I., M. Asano, S. A. Shinton, M. Gui, D. Allman, C. L. Stewart, J. Silver, and R. R. Hardy. 1999. Positive selection of natural autoreactive B cells. Science 285: 113-116.
3. Grönwall, C., J. Vas, and G. J. Silverman. 2012. Protective roles of natural IgM antibodies. Front. Immunol. 3: 66.
4. Lobo, P. I., K. H. Schlegel, C. E. Spencer, M. D. Okusa, C. Chisholm, N. McHedlishvili, A. Park, C. Christ, and C. Burtner. 2008. Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit T cell activation and chemotaxis. J. Immunol. 180: 1780-1791.
5. Baxendale, H. E., M. Johnson, R. C. M. Stephens, J. Yuste, N. Klein, J. S. Brown, and D. Goldblatt. 2008. Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease. Clin. Exp. Immunol. 151: 51-60.
6. Terasaki, P. I., V. D. Mottironi, and E. V. Barnett. 1970. Cytotoxins in disease. Autocytotoxins in lupus. N. Engl. J. Med. 283: 724-728.
7. Winfield, J. B., R. J. Winchester, P. Wernet, S. M. Fu, and H. G. Kunkel. 1975. Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum. 18: 1-8.
8. Lobo, P. I. 1981. Nature of autolymphocytotoxins present in renal hemodialysis patients. Their possible role in controlling alloantibody formation. Transplantation 32: 233-237.
9. Klouda, P. T., and M. Jeannet. 1976. Cold and warm antibodies and graft survival in kidney allograft recipients. Lancet 1: 1876-1878.
10. Lobo, P. I., L. Rudolf, and F. B. Westervelt. 1977. Enhanced kidney allograft survival across a positive crossmatch (Cx) arising from B-cell specific and cold reactive antibodies. Proc. Clin. Dial. Transpl. Forum 7: 4-6.
11. Iwaki, Y., P. I. Terasaki, M. S. Park, and R. Billing. 1978. Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet 1: 1228-1229.
12. Kerman, R. H., B. Susskind, I. Buyse, P. Pryzbylowski, J. Ruth, S. Warnell, S. A. Gruber, S. Katz, C. T. Van Buren, and B. D. Kahan. 1999. Flow cytometrydetected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Transplantation 68: 1855-1858.
13. Przybylowski, P., M. Balogna, B. Radovancevic, O. H. Frazier, B. Susskind, C. Van Buren, S. Katz, B. D. Kahan, and R. Kerman. 1999. The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients. Transplantation 67: 258-262.
14. Lobo, P. I., A. Bajwa, K. H. Schlegel, J. Vengal, S. J. Lee, L. Huang, H. Ye, U. Deshmukh, T. Wang, H. Pei, and M. D. Okusa. 2012. Natural IgM antileukocyte autoantibodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17. J. Immunol. 188: 1675-1685.
15. Chhabra, P., K. Schlegel, M. D. Okusa, P. I. Lobo, and K. L. Brayman. 2012. Naturally occurring immunoglobulin M (nIgM) autoantibodies prevent autoimmune diabetes and mitigate inflammation after transplantation. Ann. Surg. 256: 634-641.
16. Hamaguchi, Y., J. Uchida, D. W. Cain, G. M. Venturi, J. C. Poe, K. M. Haas, and T. F. Tedder. 2005. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J. Immunol. 7: 4389-4399.
17. Bajwa, A., L. Huang, E. Kurmaeva, J. Gigliotti, H. Ye, J. Miller, D. Rosin, P. I. Lobo, and M. D. Okusa. 2015. Sphingosine 1-phosphate-3 deficient dendritic cells modulate splenic responses to ischemia-reperfusion injury. J. Am. Soc. Nephrol. 27. DOI: 10. 1681/ASN. 2015010095.
18. Hinz, M., P. Löser, S. Mathas, D. Krappmann, B. Dörken, and C. Scheidereit. 2001. Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 97: 2798-2807.
19. Chen, Y., S. Khanna, C. S. Goodyear, Y. B. Park, E. Raz, S. Thiel, C. Grönwall, J. Vas, D. L. Boyle, M. Corr, et al. 2009. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J. Immunol. 183: 1346-1359.
20. Park, P., M. Haas, P. N. Cunningham, L. Bao, J. J. Alexander, and R. J. Quigg. 2002. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am. J. Physiol. Renal Physiol. 282: F352-F357.
21. Burne-Taney, M. J., N. Yokota-Ikeda, and H. Rabb. 2005. Effects of combined Tand B-cell deficiency on murine ischemia reperfusion injury. Am. J. Transplant. 5: 1186-1193.
22. Gigliotti, J. C., L. Huang, H. Ye, A. Bajwa, K. Chattrabhuti, S. Lee, A. L. Klibanov, K. Kalantari, D. L. Rosin, and M. D. Okusa. 2013. Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway. J. Am. Soc. Nephrol. 24: 1451-1460.
23. Li, L., L. Huang, H. Ye, S. P. Song, A. Bajwa, S. J. Lee, E. K. Moser, K. Jaworska, G. R. Kinsey, Y. J. Day, et al. 2012. Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J. Clin. Invest. 122: 3931-3942.
24. Schmidt, S. V., A. C. Nino-Castro, and J. L. Schultze. 2012. Regulatory dendritic cells: there is more than just immune activation. Front. Immunol. 3: 274.
25. Räch-Regué, D., M. Glancy, and A. W. Thomson. 2014. Regulatory dendritic cell therapy: from rodents to clinical application. Immunol. Lett. 161: 216-221.
26. Krempski, J., L. Karyampudi, M. D. Behrens, C. L. Erskine, L. Hartmann, H. Dong, E. L. Goode, K. R. Kalli, and K. L. Knutson. 2011. Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer. J. Immunol. 186: 6905-6913.
27. Lobo, P. I., and P. M. Suratt. 1979. Studies on the autoantibody to lymphocytes in sarcoidosis. J. Clin. Lab. Immunol. 1: 283-288.
28. Gilbreath, M. J., K. Pavanand, R. P. MacDermott, R. A. Wells, and M. A. Ussery. 1983. Characterization of cold reactive lymphocytotoxic antibodies in malaria. Clin. Exp. Immunol. 51: 232-238.
29. Dorsett, B., W. Cronin, V. Chuma, and H. L. Ioachim. 1985. Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome. Am. J. Med. 78: 621-626.
30. Williams, R. C., Jr., H. Masur, and T. J. Spira. 1984. Lymphocyte-reactive antibodies in acquired immune deficiency syndrome. J. Clin. Immunol. 4: 118-123.